The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly
Open accessAbstract
Androgen signaling through the androgen receptor (AR) directs gene expression in both normal and prostate cancer cells. Androgen regulates multiple aspects of the AR life cycle, including its localization and post-translational modification, but understanding how modifications are read and integrated with AR activity has been difficult. Here, we show that ADP-ribosylation regulates AR through a nuclear pathway mediated by Parp7. We show that Parp7 mono-ADP-ribosylates agonist-bound AR, and that ADP-ribosyl-cysteines within the N-terminal domain mediate recruitment of the E3 ligase Dtx3L/Parp9. Molecular recognition of ADP-ribosyl-cysteine is provided by tandem macrodomains in Parp9, and Dtx3L/Parp9 modulates expression of a subset of AR-regulated genes. Parp7, ADP-ribosylation of AR, and AR-Dtx3L/Parp9 complex assembly are inhibited by Olaparib, a compound used clinically to inhibit poly-ADP-ribosyltransferases Parp1/2. Our study reveals the components of an androgen signaling axis that uses a writer and reader of ADP-ribosylation to regulate protein-protein interactions and AR activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Salmon provides fast and bias-aware quantification of transcript expression
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017) · Nature Methods · doi:10.1038/nmeth.4197 · Cited by 12,700
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Watson, P. A., Arora, V. K., & Sawyers, C. L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4016 · Cited by 1,536
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Massie, C. E., Lynch, A., Ramos‐Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.158 · Cited by 624
Chemistry and Structural Biology of Androgen Receptor
Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 528
Cited by
ADP-ribosylation from molecular mechanisms to therapeutic implications
Suskiewicz, M. J., Prokhorova, E., Rack, J. G. M., & Ahel, I. (2023) · Cell · doi:10.1016/j.cell.2023.08.030 · Cited by 189
PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools
Dasovich, M., & Leung, A. K. L. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.04.009 · Cited by 79
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
Kar, P., Chatrin, C., Đukić, N., Suyari, O., Schuller, M., Zhu, K., Prokhorova, E. A., Bigot, N., Baretić, D., Ahel, J., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00126-0 · Cited by 64
“However, the macrodomains of PARP9 were also proposed as Cys-ADPr readers (Yang et al, 2021) and a viral dsRNA sensor (Xing et al, 2021).”
PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation
Ribeiro, V. C., Russo, L. C., & Hoch, N. C. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00125-1 · Cited by 44
“…currently unclear, although PARP9 and DTX3L have been shown to regulate DNA damage signalling (Yan et al, 2013), proteasomal degradation of viral proteins (Zhang et al, 2015) and activation of the androgen receptor (Yang et al, 2021), among other functions (Vela-Rodríguez and Lehtiö, 2022).”
BackgroundPARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus
Kamata, T., Yang, C., & Paschal, B. M. (2021) · Biochemical Journal · doi:10.1042/bcj20210378 · Cited by 35
Self-citation
Metadata
- Authors
- Yang, C.-S., Jividen, K., Kamata, T., Dworak, N., Oostdyk, L., Remlein, B., Pourfarjam, Y., Kim, I.-K., Du, K.-P., Abbas, T., Sherman, N. E., Wotton, D., & Paschal, B. M.
- Affiliations
- University of Virginia (US)
- University of Cincinnati (US)
- Corresponding author
- Paschal, Bryce M.
- ORCID
- Venue
- Nature Communications
- Published
- 2021-05-11
- Volume
- 12
- Issue
- 1
- Pages
- 2705-2705
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8113490
- OpenAlex
- W3161788674
- Cited by
- 44
- References
- 60
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 12 · 2023: 8 · 2022: 4 · 2021: 2
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Johns Hopkins University
- National Institutes of Health
- National Cancer Institute (R01CA214872, T32CA009109)
- National Institute of General Medical Sciences (R01GM135376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- androgen receptor, ADP-ribosylation, PARP7, PARP9, DTX3L, mono-ADP-ribosylation, E3 ubiquitin ligase, protein complex formation, androgen signaling, prostate cancer, olaparib, post-translational modification
- MeSH terms
- Poly(ADP-ribose) Polymerase Inhibitors, Poly (ADP-Ribose) Polymerase-1, ADP-Ribosylation, Adenocarcinoma, Antineoplastic Agents, Humans, Male, Neoplasm Proteins, Phthalazines, Piperazines, Poly(ADP-ribose) Polymerases, Prostatic Neoplasms, Protein Processing, Post-Translational, Receptors, Androgen, Signal Transduction, Metribolone, Gene Expression Regulation, Neoplastic, Survival Analysis, Protein Isoforms, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly. https://app.cochat.ai/papers/10.1038/s41467-021-23055-6
- The paper
- Yang, C.-S., Jividen, K., Kamata, T., Dworak, N., Oostdyk, L., Remlein, B., Pourfarjam, Y., Kim, I.-K., Du, K.-P., Abbas, T., Sherman, N. E., Wotton, D., & Paschal, B. M. (2021). Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly. Nature Communications. https://doi.org/10.1038/s41467-021-23055-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.